575 related articles for article (PubMed ID: 19606002)
1. Recurrent coagulopathy with delayed significant bleeding after crotaline envenomation.
O'Brien NF; DeMott MC; Suchard JR; Clark RF; Peterson BM
Pediatr Emerg Care; 2009 Jul; 25(7):457-9. PubMed ID: 19606002
[TBL] [Abstract][Full Text] [Related]
2. Recurrent coagulopathy and thrombocytopenia in children treated with crotalidae polyvalent immune fab: a case series.
Miller AD; Young MC; DeMott MC; Ly BT; Clark RF
Pediatr Emerg Care; 2010 Aug; 26(8):576-82. PubMed ID: 20693856
[TBL] [Abstract][Full Text] [Related]
3. Late hematologic toxicity following treatment of rattlesnake envenomation with crotalidae polyvalent immune Fab antivenom.
Ruha AM; Curry SC; Albrecht C; Riley B; Pizon A
Toxicon; 2011 Jan; 57(1):53-9. PubMed ID: 20920516
[TBL] [Abstract][Full Text] [Related]
4. Recurrent hemorrhage after western diamondback rattlesnake envenomation treated with crotalidae polyvalent immune fab (ovine).
Fazelat J; Teperman SH; Touger M
Clin Toxicol (Phila); 2008 Nov; 46(9):823-6. PubMed ID: 18608290
[TBL] [Abstract][Full Text] [Related]
5. Delayed hematologic toxicity following rattlesnake envenomation unresponsive to crotalidae polyvalent antivenom.
Bailey AM; Justice S; Davis GA; Weant K
Am J Emerg Med; 2017 Jul; 35(7):1038.e1-1038.e2. PubMed ID: 28259369
[TBL] [Abstract][Full Text] [Related]
6. Tracheal intubation prevented with administration of Fab antivenom after severe crotaline envenomation.
Bebarta VS; Ferre RM; Peck M
J Emerg Med; 2010 Jul; 39(1):e81-3. PubMed ID: 18722730
[TBL] [Abstract][Full Text] [Related]
7. Conservative management of delayed, multicomponent coagulopathy following rattlesnake envenomation.
Camilleri C; Offerman S; Gosselin R; Albertson T
Clin Toxicol (Phila); 2005; 43(3):201-6. PubMed ID: 15902796
[TBL] [Abstract][Full Text] [Related]
8. Crotalidae polyvalent immune Fab for the treatment of pediatric crotaline envenomation.
Goto CS; Feng SY
Pediatr Emerg Care; 2009 Apr; 25(4):273-9; quiz 280-2. PubMed ID: 19369845
[TBL] [Abstract][Full Text] [Related]
9. Biphasic rattlesnake venom-induced thrombocytopenia.
Offerman SR; Barry JD; Schneir A; Clark RF
J Emerg Med; 2003 Apr; 24(3):289-93. PubMed ID: 12676300
[TBL] [Abstract][Full Text] [Related]
10. Recurrent coagulopathy after antivenom treatment of crotalid snakebite.
Bogdan GM; Dart RC; Falbo SC; McNally J; Spaite D
South Med J; 2000 Jun; 93(6):562-6. PubMed ID: 10881769
[TBL] [Abstract][Full Text] [Related]
11. Recurrent and persistent coagulopathy following pit viper envenomation.
Boyer LV; Seifert SA; Clark RF; McNally JT; Williams SR; Nordt SP; Walter FG; Dart RC
Arch Intern Med; 1999 Apr; 159(7):706-10. PubMed ID: 10218750
[TBL] [Abstract][Full Text] [Related]
12. Crotalidae polyvalent immune Fab (ovine) antivenom is effective in the neutralization of South American viperidae venoms in a murine model.
Richardson WH; Tanen DA; Tong TC; Betten DP; Carstairs SD; Williams SR; Cantrell FL; Clark RF
Ann Emerg Med; 2005 Jun; 45(6):595-602. PubMed ID: 15940091
[TBL] [Abstract][Full Text] [Related]
13. Crotalidae polyvalent immune Fab: in patients with North American crotaline envenomation.
Keating GM
BioDrugs; 2011 Apr; 25(2):69-76. PubMed ID: 21443271
[TBL] [Abstract][Full Text] [Related]
14. Report of two cases: Rattlesnake venom-induced thrombocytopenia.
Odeleye AA; Presley AE; Passwater ME; Mintz PD
Ann Clin Lab Sci; 2004; 34(4):467-70. PubMed ID: 15648790
[TBL] [Abstract][Full Text] [Related]
15. Southern Pacific Rattlesnake bite: a unique clinical challenge.
Wasserberger J; Ordog G; Merkin TE
J Emerg Med; 2006 Oct; 31(3):263-6. PubMed ID: 16982358
[TBL] [Abstract][Full Text] [Related]
16. Refractory thrombocytopenia despite treatment for rattlesnake envenomation.
Gold BS; Barish RA; Rudman MS
N Engl J Med; 2004 Apr; 350(18):1912-3; discussion 1912-3. PubMed ID: 15115843
[No Abstract] [Full Text] [Related]
17. Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 2. Guidelines for clinical management with crotaline Fab antivenom.
Boyer LV; Seifert SA; Cain JS
Ann Emerg Med; 2001 Feb; 37(2):196-201. PubMed ID: 11174239
[TBL] [Abstract][Full Text] [Related]
18. Short-term outcomes after Fab antivenom therapy for severe crotaline snakebite.
Lavonas EJ; Kokko J; Schaeffer TH; Mlynarchek SL; Bogdan GM; Dart RC
Ann Emerg Med; 2011 Feb; 57(2):128-137.e3. PubMed ID: 20952098
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous Crotaline Fab antivenom for the treatment of rattlesnake envenomation in a porcine model.
Offerman SR; Barry JD; Richardson WH; Tong T; Tanen D; Bush SP; Clark RF
Clin Toxicol (Phila); 2009 Jan; 47(1):61-8. PubMed ID: 19153852
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous crotaline Fab administration in a model of rattlesnake envenomation.
Soghoian SE; Olsen D; Al Hatali BA; Hoffman RS
Clin Toxicol (Phila); 2009 Jul; 47(6):605-6; author reply 606. PubMed ID: 19586363
[No Abstract] [Full Text] [Related]
[Next] [New Search]
